Category Archives: Vascular Biology

PATHOLOGY - FACULTY OPPORTUNITIES at The University of Texas Medical Branch (UTMB) Galveston, Texas The Department of Pathology at the University of Texas Medical Branch (UTMB), Galveston, is seeking to recruit 2-3 tenure-track faculty at an academic rank of Assistant or Associate Professor with an MD, PhD, DVM or equivalent degree. The University of Texas Medical Branch: UTMB has many highly interactive research centers, biomedical institutes, and a national biocontainment laboratory with excellent infrastructure to conduct research in BSL-2, -3 and -4 on diverse animal models of infectious diseases, including arthropod containment levels 1-4 (ACL4 for tick research only) and extensive insectaries. Continue reading →

The American Heart Association has outlined 10 key features of a heart-healthy eating pattern in a new scientific statement that emphasizes the importance of overall dietary pattern rather than individual foods or nutrients and underscores the critical role of nutrition in all stages of life. Continue reading →

When older age is taken out of the equation, women undergoing PCI still face suboptimal care compared with men, Australian registry data indicate. An analysis restricted to patients younger than 55 showed more cardiovascular risk factors and delays, less radial access, and less-comprehensive medical therapy among women Continue reading →

The cows in Farmer Johns pasture lead an idyllic life. They roam through tree-shaded meadows, tearing up mouthfuls of clover while nursing their calves in tranquility Continue reading →

This article was originally published here Eur J Plast Surg. Continue reading →

By Jonathan P. Gertler, MD, and John E. Osborn, JD, MIPP Remote patient monitoring (RPM) has been present conceptually in clinical medicine for many years and its current prominence is the result of many years of evolutionary technology Continue reading →

I started yawning, and that was it. That was the sign a migraine was beginning, that I was rolling slowly down that padded cliff. Continue reading →

DURHAM, N.C., Oct. Continue reading →

RALEIGH, N.C., Oct. 4, 2021 /PRNewswire/ -- Today, the Retinal Degeneration Fund(RD Fund) the venture arm of the Foundation Fighting Blindnessand leading investor in the inherited retinal disease space announced the appointment of Anthony (Tony) Adamis, MD, to its board of directors Continue reading →

LEXINGTON, Mass., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (Keros) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need, today announced that it presented results from a preclinical study of KER-012 at the American Society for Bone and Mineral Research (ASBMR) 2021 Annual Meeting held October 1 through 4, 2021 Continue reading →